FASLG and neoplasm: Although the interaction with its cognate ligand, CD95L (FasL or CD178), can implement a caspase-dependent apoptotic signal [13–15], this receptor also exerts multiple nonapoptotic functions [16–21] and many of them are tumor promoting (reviewed in [22, 23]).